AIDS Malignancy Program

The AIDS Malignancy Program supports pre-clinical and clinical studies for the treatment of cancer in HIV+ and immunocompromised patients. The AMP also supports resources for preclinical and translational/interdisciplinary studies including a tissue repository of well characterized specimens collected from HIV+ and HIV- patients, and infrastructure at institutions that receive significant AIDS funding.

NOW AVAILABLE: 10th International Conference On Malignancies in AIDS and Other Acquired Immunodeficiencies: Basic, Epidemiologic and Clinical Research
2006 Program Book

Funding Opportunities

• PA-06-338: R21 FOA Component of PA-04-157
• NOT-CA-06-023: Notice of Availability of Administrative Supplements for Studies of Cancer in HIV/AIDS
  • Instructions for Applying to NOT-CA-06-023 (MS Word)
• PA-04-157: Research on Malignancies in AIDS and Acquired Immune Suppression
• Archives

2004 AIDS-Oncology Resources Handbook (PDF)
Current scope of NCI activities in AIDS malignancies

Note: PDF documents can be viewed by anyone with Adobe Acrobat Reader. Download the free Adobe Acrobat Reader

Other Resources

• AIDS-associated Malignancies Clinical Trials Consortium
  NCI-supported clinical trials group
• AIDS and Cancer Specimen Resource
  NCI-supported specimen resource
• AIDS International Training and Research Program
  NIH-supported program
• AIDS Malignancies Working Group
  NCI Advisory Group
• Centers for AIDS Research (CFAR)
  NIH-supported program
• HIV and AIDS Malignancy Branch, NCI
  Clinical research at NCI
• Multicenter AIDS Cohort Study MACS)
  NIH-supported multicenter, prospective study
• Women's Interagency HIV Study (WIHS)
  NIH-supported multicenter, prospective study